A transplan table pituitary mammotropic tumor (MtT) was grown in male rats of various ages to serve as a source of somatotropin (growth hormone), corticotropin (adrenocorticotropic hormone, AGTH) and prolactin. The development of the microsomal enzyme system that oxidizes hexobarbital, demethylates aminopyrine to form formaldehyde, and produces p-aminobenzoic acid by the reduction of p-nitrobenzoic acid was studied in liver from control and tumor-bearing rats.In control rats, adult levels of drug metabolism were found at 46 days of age for p-nitrobenzoic acid and at about 60 days of age for hexobarbital and aminopyrine ( fig. 1). In MtT-bearing rats, however, the normal postnatal increase in the liver enzyme system which metabolizes hexobarbital, aminopyrine, and p-nitrobenzoic acid did not occur.Since phenobarbital pretreatment of young control rats produced an increase in hepatic microsomal drug-metabolizing enzyme activity, young rats with the MtT were injected with phenobarbital. Growth of the MtT in young rats did not prevent an increase in the liver metabolism of hexobarbital or the production of formaldehyde from aminopyrine normally found to follow phenobarbital treatment (table II). Thus, while endogenous pituitary tumor somatotropin, corticotropin and prolactin may have prevented the normal maturation of the liver drug-metabolism enzyme system, enhancement of this enzyme system occurred after phenobarbital pretreatment of MtT-bearing young rats.
SpeculationThe decreased activity of microsomal drug-metabolizing enzymes in liver from young rats with high levels of somatotropin, corticotropin and prolactin in blood, compared with that from control animals, suggests that these pituitary hormones, singularly or in combination, may affect the activity as well as the postnatal development of this enzyme system in the rat. A relation between blood levels of these hormones and liver drug-metabolizing enzyme activity in young animals of various species may exist. A possible interrelation between liver drug-metabolizing enzyme activity and high blood levels of somatotropin in newborn infants may also exist.